51 related articles for article (PubMed ID: 26318067)
1. Design, synthesis, biological evaluation, and in silico studies of novel pyridopyridine derivatives as anticancer candidates targeting FMS kinase.
Sebastian A; Abu Rabah RR; Zaraei SO; Vunnam S; Sultan S; Anbar HS; El-Gamal R; Tarazi H; Sarg N; Alhamad DW; Al Shamma SA; Shahin AI; Omar HA; Al-Tel TH; El-Gamal MI
Eur J Med Chem; 2024 Aug; 274():116557. PubMed ID: 38850857
[TBL] [Abstract][Full Text] [Related]
2. Exploration of isoxazole analogs: Synthesis, COX inhibition, anticancer screening, 3D multicellular tumor spheroids, and molecular modeling.
Hawash M; Abdallah S; Abudayyak M; Melhem Y; Abu Shamat M; Aghbar M; Çapan I; Abualhasan M; Kumar A; Kamiński M; Góral T; Dominiak PM; Sobuh S
Eur J Med Chem; 2024 May; 271():116397. PubMed ID: 38626522
[TBL] [Abstract][Full Text] [Related]
3. 1,2,3-Triazole-totarol conjugates as potent PIP5K1α lipid kinase inhibitors.
Haidar S; Amesty Á; Oramas-Royo S; Götz C; El-Awaad E; Kaiser J; Bödecker S; Arnold A; Aichele D; Amaro-Luis JM; Estévez-Braun A; Jose J
Bioorg Med Chem; 2024 May; 105():117727. PubMed ID: 38669736
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel FGFR4 inhibitors through a build-up fragment strategy.
Kim J; Im CG; Oh K; Lee JM; Al-Rubaye F; Min KH
J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2343350. PubMed ID: 38655602
[TBL] [Abstract][Full Text] [Related]
5. Discovery of LHQ490 as a highly selective fibroblast growth factor receptor 2 (FGFR2) inhibitor.
Li H; Ke R; Zhou Y; Chang S; Wang J; Su C; Wu P; Yang B; Wang Z; Ding K; Ma D
Eur J Med Chem; 2024 Jun; 272():116473. PubMed ID: 38718625
[TBL] [Abstract][Full Text] [Related]
6. Adamantyl arotinoids that inhibit IκB kinase α and IκB kinase β.
Lorenzo P; Ortiz MA; Alvarez R; Piedrafita FJ; de Lera AR
ChemMedChem; 2013 Jul; 8(7):1184-98. PubMed ID: 23653373
[TBL] [Abstract][Full Text] [Related]
7. A review of synthetic strategy, SAR, docking, simulation studies, and mechanism of action of isoxazole derivatives as anticancer agents.
Arya GC; Khalid M; Mehla S; Jakhmola V
J Biomol Struct Dyn; 2024 Jun; 42(9):4909-4935. PubMed ID: 37315986
[TBL] [Abstract][Full Text] [Related]
8. Network pharmacology and experimental insights into STAT3 inhibition by novel isoxazole derivatives of piperic acid in triple negative breast cancer.
Yatoo GN; Bhat BA; Zubaid-Ul-Khazir ; Asif M; Bhat SA; Gulzar F; Rashied F; Wani AH; Ahmed I; Zargar SM; Mir MA; Banday JA
Fitoterapia; 2024 Jun; 175():105927. PubMed ID: 38548028
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis and Biological Evaluation of Novel Anticancer Amidinourea Analogues via Unexpected 1,3,5-Triazin-2-one Ring Opening.
Grytsai O; Hamouda-Tekaya N; Botton T; Rocchi S; Benhida R; Ronco C
ChemMedChem; 2024 Feb; 19(3):e202300493. PubMed ID: 38126619
[TBL] [Abstract][Full Text] [Related]
10. Exploring the impact of trifluoromethyl (-CF
Pattanayak P; Nikhitha S; Halder D; Ghosh B; Chatterjee T
RSC Adv; 2024 Jun; 14(27):18856-18870. PubMed ID: 38873543
[TBL] [Abstract][Full Text] [Related]
11. Approved Small-Molecule ATP-Competitive Kinases Drugs Containing Indole/Azaindole/Oxindole Scaffolds: R&D and Binding Patterns Profiling.
Zhang H; He F; Gao G; Lu S; Wei Q; Hu H; Wu Z; Fang M; Wang X
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770611
[TBL] [Abstract][Full Text] [Related]
12. New Oxazolo[5,4-
Sochacka-Ćwikła A; Mączyński M; Czyżnikowska Ż; Wiatrak B; Jęśkowiak I; Czerski A; Regiec A
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232997
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel isoxazole-carboxamide derivatives as promising agents for melanoma and targeted nano-emulgel conjugate for improved cellular permeability.
Hawash M; Jaradat N; Eid AM; Abubaker A; Mufleh O; Al-Hroub Q; Sobuh S
BMC Chem; 2022 Jun; 16(1):47. PubMed ID: 35751124
[TBL] [Abstract][Full Text] [Related]
14. Research trends in pharmacological modulation of tumor-associated macrophages.
Wang N; Wang S; Wang X; Zheng Y; Yang B; Zhang J; Pan B; Gao J; Wang Z
Clin Transl Med; 2021 Jan; 11(1):e288. PubMed ID: 33463063
[TBL] [Abstract][Full Text] [Related]
15. Discovery of 5-methyl-
Im D; Moon H; Kim J; Oh Y; Jang M; Hah JM
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1110-1115. PubMed ID: 32338093
[TBL] [Abstract][Full Text] [Related]
16. The synthetic and therapeutic expedition of isoxazole and its analogs.
Agrawal N; Mishra P
Med Chem Res; 2018; 27(5):1309-1344. PubMed ID: 32214770
[TBL] [Abstract][Full Text] [Related]
17. Conformational restriction of a type II FMS inhibitor leading to discovery of 5-methyl-
Im D; Moon H; Kim J; Oh Y; Jang M; Hah JM
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1716-1721. PubMed ID: 31571509
[TBL] [Abstract][Full Text] [Related]
18. Novel Methylselenoesters as Antiproliferative Agents.
Díaz-Argelich N; Encío I; Plano D; Fernandes AP; Palop JA; Sanmartín C
Molecules; 2017 Aug; 22(8):. PubMed ID: 28767087
[TBL] [Abstract][Full Text] [Related]
19. Discovery of 4-arylamido 3-methyl isoxazole derivatives as novel FMS kinase inhibitors.
Im D; Jung K; Yang S; Aman W; Hah JM
Eur J Med Chem; 2015 Sep; 102():600-10. PubMed ID: 26318067
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
